Organs may be printed to order and rationed anyway

Imagine an allocation policy written in 2050 for a health system in which organs can be printed. The document would open by confirming the part its authors expect the public to find hardest: that a waiting list still exists. It would then spend forty pages explaining that this is a different waiting list, for a different scarcity, in the evident belief that this is a comfort.

The scarce thing would no longer be the organ. It would be the printer: how many build chambers a region has, how many weeks each one is occupied by a single kidney, how much maturation space the result then needs, and how many technicians are qualified to sign the release. Beneath that would sit a second scarcity, quieter and worse — the quality of the patient's own cell line, which would vary with age, illness and the number of previous attempts.

That is where the clause everyone objects to and nobody can replace would come from. A patient whose cells yield a difficult line consumes more manufacturing time for a worse expected outcome. A points system that ignores this wastes capacity. A points system that accounts for it awards fewer points to people for being ill in the wrong way — which is, in one sentence, the thing medicine has spent a century trying not to do.

“The system does not rank people,” a spokesperson for the allocation authority would say. “It ranks expected outcomes per unit of manufacturing capacity. I understand that from the corridor those look identical. From inside the committee they also look identical. The difference is that one of them has to be written down.”

The scoring would be published, because publishing it would be the only defensible option, and almost nobody would read it until the first case in which two patients were separated by a single point. From that day the document would become a national text, and the country would discover that it contained a coefficient it had approved without discussion.

Appeals would age worst of all. A patient could contest the inputs — the lab values, the comorbidity codes, the cell line grade — but not the weights, because the weights would be described as clinical rather than administrative, and clinical questions are referred to the committee that was consulted when the weights were set.

The proposition here is not technological. It is that abundance relocates rationing rather than ending it: from the availability of a thing to the throughput of the machine that makes it, and from a donor's death to a number somebody chose. Every health system that has ever expanded a capacity has watched the queue reassemble one step further down the line, under a different name.